Skip to content
Home/Companies/Biotech/BioThrust

BioThrust

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns BioThrust?

BioThrust is currently owned by Freigeist Capital through Freigeist Deep-Tech Evergreen (2017 vintage), since 2024.

Hand-verified · updated 2026-07-03

Freigeist Capital
Investor
Freigeist Capital
Freigeist Deep-Tech Evergreen · 2017 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from Freigeist Deep-Tech Evergreen

Other portfolio companies in the same fund.

Akina
Akina
Active
MedTechSwitzerland· 2025
Collie
Collie
Active
SoftwareGermany· 2025
United Manufacturing Hub
Active
SoftwareGermany· 2024
Leko Labs
Active
ConstructionLuxembourg· 2022
Prosion
Prosion
Active
BiotechGermany· 2022
BUILD.ONE
Build.one
Active
SoftwareGermany· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track BioThrust

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy BioThrust?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on BioThrust.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue